Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer

(2011) Wilfred Truin et al.   BREAST

Invasive Lobular vs. Ductal Breast Cancer: A Stage-Matched Comparison of Outcomes

(2010) Nabil Wasif et al.   ANNALS OF SURGICAL ONCOLOGY

Clinicopathological Characteristics of Invasive Lobular Carcinoma of the Breast

(2010) Takeshi Hanagiri et al.   Asian Journal of Surgery

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to st gallen consensus and intrinsic subtypes

(2010) So-Youn Jung et al.   JOURNAL OF SURGICAL ONCOLOGY

The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis

(2010) Aparna Suryadevara et al.   World Journal of Surgical Oncology

Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers

(2009) Ankit Bharat et al.   AMERICAN JOURNAL OF SURGERY

The Yale University Experience of Early-Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical-Pathologic Features, Long-Term Outcomes, and Molecular Expression of COX-2, Bcl-2, and p53 as a Function of Histology

(2009) Meena S. Moran et al.   Breast Journal

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma

(2009) James W Horvath et al.   World Journal of Surgical Oncology

The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology

(2008) Emad A. Rakha et al.   BREAST CANCER RESEARCH AND TREATMENT

Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series

(2008) Giuseppe Viale et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutations in p53, p53 protein overexpression and breast cancer survival

(2008) Pavel Rossner Jr et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

(2008) Bernhard C. Pestalozzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

(2008) Giuseppe Viale et al.   JNCI-Journal of the National Cancer Institute